Biosensors Market by Application (POC, Home Diagnostics, Research Labs, Biodefense, Environmental Monitoring, Food & Beverages Industry), Technology, Product (Wearable and Non-Wearable), and Geography - Global Forecast to 2022

The biosensors market was valued at USD 15.96 Billion in 2016 and is likely to reach USD 27.06 Billion by 2022, at a CAGR of 8.84% during the forecast period. The base year used for this study is 2016, and the forecast period considered is between 2017 and 2022.

The objectives of the study are as follows:

• To define, describe, and forecast the biosensors market segmented on the basis of product, technology, application, and geography
• To forecast the market size of the various segments with respect to four main regions North America, Europe, Asia Pacific (APAC), and Rest of the World (RoW)
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the total market
• To strategically profile the key players and comprehensively analyze their market shares and core competencies, along with detailing the competitive landscape for market leaders
• To analyze the competitive developments such as agreements, contracts, partnerships, mergers & acquisitions, new product developments, and research & development (R&D) carried out in the biosensors market

The research methodology used to estimate and forecast the biosensors market begins with obtaining data on key vendor revenues through secondary research. Some of the secondary sources referred to for this research include information from various journals and databases such as IEEE journals, Factiva, Hoovers, and OneSource. The vendor offerings have also been taken into consideration to determine the market segmentation. The bottom-up procedure has been employed to arrive at the overall size of the biosensors market from the revenues of the key players in the market. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews of officials holding key positions in the industry such as CEOs, VPs, directors, and executives. The market breakdown and data triangulation procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The breakdown of the profiles of primaries has been depicted in the figure below.

To know about the assumptions considered for the study, download the pdf brochure

The biosensors ecosystem comprises manufacturers of biosensors and biosensor-related technology and service vendors such as Abbott Point of Care Inc. (US), Medtronic, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Siemens AG (Germany), LifeScan, Inc. (US), LifeSensors Inc. (US), Nova Biomedical Corp. (US), Acon Laboratories Inc. (US), Universal Biosensors (Australia), Pharmaco-Kinesis Corporation (PKC) (US), Bayer Healthcare AG (Germany), Biacore (UK), Bio-Rad Laboratories Inc. (US), Biosensors International Ltd. (Singapore), Ercon, Inc. (US), DuPont (US), and Sysmex Corporation (Japan). These vendors sell products and provide services to end users to cater to their specific requirements.

The Target Audience:

• Biosensors Service Providers
• Manufacturing Companies
• Research Organizations
• Ballast Water Treatment-Related Associations, Organizations, Forums, and Alliances
• Distributors, Resellers, and Traders
• Government Bodies such as Regulating Authorities and Policy Makers
• Venture Capitalists, Private Equity Firms, and Startup Companies

“The study answers several questions for the target audiences, primarily which market segments to focus on in next two to five years for prioritizing the efforts and investments.

Report Scope:

The biosensors market has been segmented into the following categories.

Biosensors Market, by Application:

• Point of Care
• Home Diagnostics
• Research Labs
• Biodefense
• Environmental Monitoring
• Food & Beverages Industry

Biosensors Market, by Type:

• Electrochemical Biosensors
• Piezoelectric Biosensors
• Optical Biosensors
• Thermal Biosensors
• Nanomechanical Biosensors
• Others

Biosensors Market, by Product:

• Wearable Biosensors
• Non-Wearable Biosensors

Biosensors Market, by Geography:

• North America (US, Canada, and Mexico)
• Europe (Germany, UK, France, Italy, Spain, and Rest of Europe)
• Asia Pacific (Japan, China, India, and Rest of APAC)
• Rest of the World

Available Customizations:

With the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five)

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Study Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for This Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 List of Major Secondary Sources
                    2.1.1.2 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Primary Interviews With Experts
                    2.1.2.2 Breakdown of Primaries
                    2.1.2.3 Key Data From Primary Sources
                    2.1.2.4 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
                    2.2.2.1 Estimating Value and Volume From Secondary Treasures
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions

3 Executive Summary (Page No. - 30)

4 Premium Insights (Page No. - 34)
    4.1 Attractive Growth Opportunities in the Biosensors Market
    4.2 Biosensors Market, By Application
    4.3 Biosensors Market, By Technology and Region
    4.4 Biosensors Market, By Product
    4.5 Biosensors Market, By Country

5 Market Overview (Page No. - 37)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Emergence of Nanotechnology-Based Biosensors
                    5.2.1.2 Significant Technological Advancements in the Past Few Years
                    5.2.1.3 Increasing Use of Biosensors to Monitor Glucose Levels in Individuals With Diabetes
                    5.2.1.4 Increased Demand for Home-Based PoC Devices
           5.2.2 Restraints
                    5.2.2.1 Slow Rate of Commercialization
                    5.2.2.2 High Costs Involved in Research and Development
                    5.2.2.3 Reluctance Toward the Adoption of New Treatment Practices
           5.2.3 Opportunities
                    5.2.3.1 Emerging Market in Developing Countries
                    5.2.3.2 High-Growth Opportunities in Environmental Monitoring, Biodefense, and the Food Industry
           5.2.4 Challenges
                    5.2.4.1 Government Regulations – Long Certification and Approval Cycles
                    5.2.4.2 Pricing Pressure in the PoC Market

6 Industry Trends (Page No. - 45)
    6.1 Introduction
    6.2 Value Chain Analysis
    6.3 Industry Trends
    6.4 Porter’s Five Forces Analysis
           6.4.1 Threat of New Entrants
           6.4.2 Threats of Substitutes
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Bargaining Power of Buyers
           6.4.5 Intensity of Competitive Rivalry
    6.5 Startup Scenario
           6.5.1 Start-Up Companies

7 Market, By Technology (Page No. - 53)
    7.1 Introduction
    7.2 Electrochemical Biosensors
           7.2.1 Amperometric Sensors
                    7.2.1.1 Blood Glucose Sensors
           7.2.2 Potentiometric Sensors
                    7.2.2.1 Immunosensors
           7.2.3 Conductometric Sensors
    7.3 Optical Biosensors
           7.3.1 Surface Plasmon Resonance (SPR)
           7.3.2 Calorimetric Biosensors
           7.3.3 Fluorescence Biosensors
    7.4 Piezoelectric Biosensors
           7.4.1 Acoustic Biosensors
           7.4.2 Microcantilever Biosensors
    7.5 Thermal Biosensors
    7.6 Nanomechanical Biosensors
    7.7 Others

8 Biosensors Market, By Product (Page No. - 64)
    8.1 Introduction
    8.2 Wearable Biosensors
           8.2.1 Wristwear
           8.2.2 Eyewear
           8.2.3 Footwear
           8.2.4 Neckwear
           8.2.5 Bodywear
           8.2.6 Others
    8.3 Non-Wearable Biosensors

9 Biosensors Market, By Application (Page No. - 72)
    9.1 Introduction
    9.2 Point of Care (PoC)
           9.2.1 Biosensors Market for PoC Applications, By Geography
           9.2.2 Glucose Monitoring
           9.2.3 Cardiac Markers
           9.2.4 Infectious Diseases
           9.2.5 Coagulation Monitoring
           9.2.6 Pregnancy & Fertility Testing
           9.2.7 Blood Gas & Electrolytes
           9.2.8 Tumor Or Cancer Markers
           9.2.9 Urinalysis Testing
           9.2.10 Cholesterol Tests
           9.2.11 Others
    9.3 Home Diagnostics
    9.4 Research Labs
           9.4.1 Drug Development
    9.5 Biodefence
           9.5.1 Crime Detection
    9.6 Environmental Monitoring
           9.6.1 Wastewater Treatment
    9.7 Food & Beverages Industry

10 Biosensors Market, By Geography (Page No. - 105)
     10.1 Introduction
     10.2 North America
     10.3 Europe
     10.4 Asia Pacific (APAC)
     10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. - 117)
     11.1 Overview
     11.2 Key Players in Biosensors Market
     11.3 Dive Chart Analysis
             11.3.1 Vanguards
             11.3.2 Dynamic
             11.3.3 Innovator
             11.3.4 Emerging
     11.4 Competitive Benchmarking
             11.4.1 Product Offerings
             11.4.2 Business Strategy
*Top 25 Companies Analyzed for This Study are - F. Hoffman-LA Roche Ltd. (Switzerland), Abbott Point of Care Inc. (Us), Medtronic, Inc. (Us), Lifescan Inc. (Us), Universal Biosensors Inc. (Australia), Dupont (Us), Sysmex Corporation (Japan), Bio-Rad Laboratories Inc. (Us), Pharmaco-Kinesis Corporation (Pkc) (Us), Nova Biomedical Corp. (Us), ACON Laboratories, Inc. (Us), Lifesensors Inc. (Us), Biacore (Sweden), Biosensors International Pte. Ltd. (Us), Innovative Biosensors, Inc. (Us), Xsensio (Switzerland), Theron, Inc. (Us), Cranfield Biotechnology Centre (Uk), Ercon, Inc. (Us), Bio-Rad Laboratories Inc. (Us), Draeger Safety (Us), Molecular Devices Corp. (Us), M-Biotech, Neurosky, Inc. (Us), and Qtl Biosystems, LLC (Us)
     11.5 Competitive Situations and Trends
             11.5.1 New Product Launches and Developments
             11.5.2 Partnerships, Collaborations, and Agreements
             11.5.3 Mergers and Acquisitions
             11.5.4 Expansions

12 Company Profiles (Page No. - 128)
     12.1 Introduction
(Business Overview, Products Offered & Services Strategies, Key Insights, Recent Developments, MnM View)*
     12.2 Abbott Point of Care, Inc.
     12.3 F. Hoffman-LA Roche Ltd.
     12.4 Medtronic Inc.
     12.5 Universal Biosensors, Inc.
     12.6 Siemens AG
     12.7 Lifescan, Inc.
     12.8 Lifesensors, Inc.
     12.9 Nova Biomedical
     12.10 ACON Laboratories, Inc.
     12.11 Pharmaco-Kinesis Corporation
     12.12 Bayer Healthcare AG
     12.13 Bio-Rad Laboratories, Inc.
     12.14 Biacore
     12.15 Biosensors International Pte. Ltd.
     12.16 Ercon, Inc.
     12.17 Dupont
     12.18 Sysmex Corporation
     12.19 Key Innovators
             12.19.1 Neurosky, Inc.
             12.19.2 Graphene Frontiers
             12.19.3 Hmicro Inc.

*Details on Business Overview, Products Offered & Services Strategies, Key Insights, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 174)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports
     13.7 Author Details

List of Tables (73 Tables)

Table 1 Biosensors Market, By Technology, 2015–2022 (USD Billion)
Table 2 Differences Between Various Electrochemical Biosensors
Table 3 Glucose Sensors and Devices Approved By Food and Drug Administration (Fda)
Table 4 Market for Electrochemical Biosensors, By Technology, 2015–2022 (USD Billion)
Table 5 Market for Optical Biosensors, By Technology, 2015–2022 (USD Billion)
Table 6 Biosensors Market, By Product, 2015–2022 (USD Billion)
Table 7 Market for Wearable Biosensors, By Application, 2015–2022 (USD Million)
Table 8 Market for Wristwear Biosensors, By Application, 2015–2022 (USD Million)
Table 9 Market for Eyewear Headwear Biosensors, By Application, 2015–2022 (USD Million)
Table 10 Market for Footwear Biosensors, By Application, 2015–2022 (USD Million)
Table 11 Market for Neckwear Biosensors, By Application, 2015–2022 (USD Million)
Table 12 Market for Bodywear Biosensors, By Application, 2015–2022 (USD Million)
Table 13 Market for Other Wearable Biosensors, By Application, 2015–2022 (USD Million)
Table 14 Market for Non-Wearable Biosensors, By Application, 2015–2022 (USD Billion)
Table 15 Market, By Application, 2015–2022 (USD Billion)
Table 16 Market for PoC Applications, By Type, 2015–2022 (USD Billion)
Table 17 Market for PoC Applications, By Region, 2015–2022 (USD Billion)
Table 18 Biosensors Market for PoC Applications in North America, By Country, 2015–2022 (USD Billion)
Table 19 Market for PoC Applications in Europe, By Country/Region, 2015–2022 (USD Billion)
Table 20 Market for PoC Applications in APAC, By Country/Region, 2015–2022 (USD Billion)
Table 21 Market for PoC Applications, By Product, 2015–2022 (USD Billion)
Table 22 Market for Wearable Biosensors for PoC Applications, By Type, 2015–2022 (USD Billion)
Table 23 Biosensors Market for Glucose Monitoring, By Region, 2015–2022 (USD Billion)
Table 24 Market for Cardiac Markers, By Region, 2015–2022 (USD Million)
Table 25 Market for Infectious Diseases, By Region, 2015–2022 (USD Million)
Table 26 Market for Coagulation Monitoring, By Region, 2015–2022 (USD Million)
Table 27 Biosensors Market for Pregnancy & Fertility Testing, By Region, 2015–2022 (USD Million)
Table 28 Market for Blood Gas & Electrolytes, By Region, 2015–2022 (USD Million)
Table 29 Market for Tumor Or Cancer Markers, By Region, 2015–2022 (USD Million)
Table 30 Biosensors Market for Urinalysis Testing, By Region, 2015–2022 (USD Million)
Table 31 Market for Cholesterol Tests, By Region, 2015–2022 (USD Million)
Table 32 Biosensors Market for Other PoC Applications, By Region, 2015–2022 (USD Million)
Table 33 Market for Home Diagnostics Applications, By Region, 2015–2022 (USD Billion)
Table 34 Biosensors Market for Home Diagnostics Applications in North America, By Country, 2015–2022 (USD Million)
Table 35 Biosensors Market for Home Diagnostics Applications in Europe, By Country/Region, 2015–2022 (USD Million)
Table 36 Market for Home Diagnostics Applications in APAC, By Country/Region, 2015–2022 (USD Billion)
Table 37 Biosensors Market for Home Diagnostics Applications, By Product, 2015–2022 (USD Billion)
Table 38 Market for Wearable Biosensors for Home Diagnostics Applications, By Type, 2015–2022 (USD Million)
Table 39 Biosensors Market for Research Lab Applications, By Region, 2015–2022 (USD Billion)
Table 40 Market for Research Lab Applications in North America, By Country, 2015–2022 (USD Million)
Table 41 Market for Research Lab Applications in Europe, By Country/Region, 2015–2022 (USD Million)
Table 42 Market for Research Lab Applications in APAC, By Country/Region, 2015–2022 (USD Million)
Table 43 Biosensors Market for Research Lab Applications, By Product, 2015–2022 (USD Billion)
Table 44 Market for Wearable Biosensors for Research Lab Applications, By Type, 2015–2022 (USD Million)
Table 45 Market for Biodefense Applications, By Region, 2015–2022 (USD Million)
Table 46 Biosensors Market for Biodefense Applications in North America, By Country, 2015–2022 (USD Million)
Table 47 Market for Biodefense Applications in Europe, By Country/Region, 2015–2022 (USD Million)
Table 48 Biosensors Market for Biodefense Applications in APAC, By Country/Region, 2015–2022 (USD Million)
Table 49 Market for Biodefense Applications, By Product, 2015–2022 (USD Million)
Table 50 Market for Wearable Biosensors for Biodefense Applications, By Type, 2015–2022 (USD Million)
Table 51 Biosensors Market for Environmental Monitoring Applications, By Region, 2015–2022 (USD Billion)
Table 52 Market for Environmental Monitoring Applications in North America, By Country, 2015–2022 (USD Million)
Table 53 Biosensors Market for Environmental Monitoring Applications in Europe, By Country/Region, 2015–2022 (USD Million)
Table 54 Biosensors Market for Environmental Monitoring Applications in APAC, By Country/Region, 2015–2022 (USD Million)
Table 55 Market for Environmental Monitoring Applications, By Product, 2015–2022 (USD Billion)
Table 56 Market for Wearable Biosensors for Environmental Monitoring Applications, By Type, 2015–2022 (USD Billion)
Table 57 Enzyme Biosensor for Detecting Food Components
Table 58 Market for Food & Beverages Industry, By Region, 2015–2022 (USD Million)
Table 59 Biosensors Market for the Food & Beverages Industry in North America, By Country, 2015–2022 (USD Million)
Table 60 Market for the Food & Beverages Industry in Europe, By Country/Region, 2015–2022 (USD Million)
Table 61 Biosensors Market for the Food & Beverages Industry in APAC, By Country/Region, 2015–2022 (USD Billion)
Table 62 Biosensors Market, By Region, 2015–2022 (USD Billion)
Table 63 Market in North America, By Country, 2015–2022 (USD Billion)
Table 64 Biosensors Market in North America, By Application, 2015–2022 (USD Billion)
Table 65 Market in Europe, By Country/Region, 2015–2022 (USD Billion)
Table 66 Biosensors Market in Europe, By Application, 2015–2022 (USD Billion)
Table 67 Market in APAC, By Country/Region, 2015–2022 (USD Billion)
Table 68 Biosensors Market in APAC, By Application, 2015–2022 (USD Billion)
Table 69 Market in RoW, By Application, 2015–2022 (USD Million)
Table 70 New Product Launches and Developments (2014–2017)
Table 71 Partnerships, Collaborations, and Agreements (2016—2017)
Table 72 Mergers and Acquisitions (2015–2017)
Table 73 Expansions (2016 & 2017)

List of Figures (86 Figures)

Figure 1 Biosensor Market: Process Flow of Market Size Estimation
Figure 2 Biosensors Market: Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Biosensors Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation
Figure 6 Point of Care Applications to Hold the Largest Size of the Biosensors Market By 2022
Figure 7 Non-Wearable to Dominate the Biosensors Market During Forecast Period
Figure 8 Market for Optical Biosensors to Grow at the Highest Rate During the Forecast Period
Figure 9 North America to Hold the Largest Share of the Biosensors Market in 2017
Figure 10 Biosensors Market in APAC to Witness the Highest Growth During the Forecast Period
Figure 11 Point of Care to Hold the Largest Size of the Market By 2022
Figure 12 Electrochemical Biosensors to Hold the Largest Share of the Biosensors Market in 2017
Figure 13 Non-Wearable Biosensors to Hold A Larger Share of the Market By 2022
Figure 14 Us to Hold the Largest Share of the Biosensors Market in 2017
Figure 15 Increased Monitoring of Diabetic Individuals and Demand for Home-Based Pc Devices to Fuel the Growth of the Biosensors Market
Figure 16 Miniaturization – A Leading Trend in the Current Biosensors Market
Figure 17 Porter’s Five Forces Analysis
Figure 18 Low Impact of the Threat of New Entrants on the Market
Figure 19 Medium Impact of the Threat of Substitute on the Biosensors Market
Figure 20 Medium Impact of the Bargaining Power of Supplier on the Market
Figure 21 High Impact of the Bargaining Power of Buyers on the Biosensors Market
Figure 22 Medium Impact of the Intensity of Competitive Rivalry on the Market
Figure 23 Total Investment Raised By the Start-Ups
Figure 24 Biosensors Market, By Technology
Figure 25 Segmentation of Electrochemical Biosensors
Figure 26 Segmentation of Optical Biosensors
Figure 27 Segmentation of Piezoelectric Biosensors
Figure 28 Biosensors Market, By Product
Figure 29 Market, By Application (2017–2022)
Figure 30 Biosensors Market for PoC Applications in APAC to Grow at the Highest Rate During the Forecast Period
Figure 31 North America to Hold the Largest Size of the Market for Glucose Monitoring Applications By 2022
Figure 32 Europe to Hold the Largest Share of the Biosensors Market for Coagulation Monitoring Applications By 2022
Figure 33 Europe to Hold the Largest Size of the Biosensors Market for Tumor Or Cancer Markers in 2017
Figure 34 North America to Hold the Largest Share of the Market for Home Diagnostics Applications By 2022
Figure 35 Non-Wearable Biosensors to Hold A Larger Share of the Market for Home Diagnostics Applications By 2022
Figure 36 Market for Research Lab Applications in APAC to Grow at the Highest Rate Between 2017 and 2022
Figure 37 Non-Wearable Biosensors to Dominate the Biosensors Market for Research Lab Applications During the Forecast Period
Figure 38 Biosensors Market for Biodefense Applications in APAC to Grow at the Highest Rate During the Forecast Period
Figure 39 Market for Wearable Biosensors for Biodefense Applications to Grow at the Highest Rate During the Forecast Period
Figure 40 Biosensors Market for Environmental Monitoring Applications in APAC to Grow at the Highest Rate During the Forecast Period
Figure 41 Market for Wearable Sensors for Environmental Monitoring Applications to Grow at A Higher Rate During the Forecast Period
Figure 42 Geographic Snapshot of the Biosensors Market (2016)
Figure 43 Snapshot of the Biosensors Market in North America
Figure 44 Snapshot of the Market in Europe
Figure 45 Snapshot of the Biosensors Market in APAC
Figure 46 Market Share Analysis of Key Players in the Biosensors Industry, 2016
Figure 47 Biosensors Market Overview: Dive Analysis
Figure 48 Market Evolution Framework—New Product Launches/Developments Emerged as the Major Strategy Adopted By the Market Players
Figure 49 Battle for Market Share: New Product Launches and Developments Were the Key Growth Strategies
Figure 50 Abbott Laboratories: Company Snapshot
Figure 51 Abbott Laboratories: Products Offerings
Figure 52 Abbott Laboratories: Business Strategies
Figure 53 F. Hoffman-LA Roche Ltd.: Business Overview
Figure 54 F. Hoffman-LA Roche Ltd.: Products Offerings
Figure 55 F. Hoffman-LA Roche Ltd.: Business Strategies
Figure 56 Medtronic, Inc.: Business Overview
Figure 57 Medtronic, Inc.: Products Offerings
Figure 58 Medtronic, Inc.: Business Strategies
Figure 59 Universal Biosensors, Inc.: Business Overview
Figure 60 Universal Biosensors, Inc.: Products Offerings
Figure 61 Universal Biosensors, Inc.: Business Strategies
Figure 62 Siemens AG: Business Overview
Figure 63 Siemens AG: Products Offerings
Figure 64 Siemens AG: Business Strategies
Figure 65 Lifescan, Inc.: Products Offerings
Figure 66 Lifescan, Inc.: Business Strategies
Figure 67 Lifesensors, Inc.: Products Offerings
Figure 68 Lifesensors, Inc.: Business Strategies
Figure 69 Nova Biomedical: Products Offerings
Figure 70 Nova Biomedical: Business Strategies
Figure 71 ACON Laboratories, Inc.: Products Offerings
Figure 72 ACON Laboratories, Inc.: Business Strategies
Figure 73 Pharmaco-Kinesis Corporation: Products Offerings
Figure 74 Pharmaco-Kinesis Corporation: Business Strategies
Figure 75 Bayer Healthcare AG: Business Overview
Figure 76 Bayer Healthcare AG: Products Offerings
Figure 77 Bayer Healthcare AG: Business Strategies
Figure 78 Bio-Rad Laboratories, Inc.: Company Snapshot
Figure 79 Bio-Rad Laboratories, Inc.: Products Offerings
Figure 80 Bio-Rad Laboratories, Inc.: Business Strategies
Figure 81 Dupont: Company Snapshot
Figure 82 Dupont: Products Offerings
Figure 83 Dupont: Business Strategies
Figure 84 Sysmex Corporation: Company Snapshot
Figure 85 Sysmex Corporation: Products Offerings
Figure 86 Sysmex Corporation: Business Strategies

The biosensors market was valued at USD 15.96 Billion in 2016 and is expected to reach USD 27.06 Billion by 2022, at a CAGR of 8.84% during the forecast period. The market growth can be attributed to the continuous technological advancements in the biosensors ecosystem, increase in the use of biosensors for nonmedical applications, lucrative growth in POC diagnostics, and rise in the demand for glucose monitoring systems.

In this report, the biosensors market has been segmented on the basis of application, technology, product, and geography. In 2016, POC applications accounted for the largest share of the overall biosensors market. The development of accurate and rapid testing kits is contributing to the growth of the biosensors market for POC applications.

Among wearable biosensors, wristwear biosensors accounted for the largest size of the biosensors market in 2016. Wristwear devices for fitness and wellness such as smart watches and wrist bands are already available in the market and are gaining popularity. These devices include  smart watches and wrist bands. Constant technological innovations, easy-to-use user interface, real-time health monitoring, and cost effectiveness are the major factors driving the market for wristwear applications.

The market for optical biosensors is expected to grow at a rate between 2017 and 2022. Optical biosensors are commonly used to analyze biomolecular interactions as these sensors can determine affinity and kinetics of a wide variety of molecular interactions in real time, without requiring a molecular tag or label. New applications are being discovered for optical sensors such as drug discovery, including target identification, ligand fishing, assay development, and manufacturing quality control. All these factors are responsible for the highest growth of the market for optical sensors between 2017 and 2022.

North America is likely to hold the largest share of the overall biosensors market in 2017. POC diagnostics is the fastest-growing applications for biosensors in North America. The main reason behind the growth of the POC segment is the increase in addressable patient population base. The increase in the waiver of Clinical Laboratory Improvement Amendments (CLIA) for certain POC diagnostic devices such as coagulation, glucose monitoring, and hematology devices is further driving the growth of the biosensors market in North America.

According to International Diabetes Federation, the number of people suffering from diabetes is expected to grow from 415 million in 2015 to almost 642 million by 2040 worldwide; this would increase the demand for biosensors used for monitoring glucose. The emergence of the nanobiosensors, rapid technological advancements in the biosensors ecosystem, growing demand for glucose monitoring systems, and rising demand for home-based POC devices are driving the growth of the biosensors market.

The high cost incurred in the research and development and slow rate of commercialization are key factors inhibiting the growth of the biosensors market. Also, stringent government regulations pose a key challenge for industry players.

Some of the major players operating in the biosensors market are Abbott Point of Care Inc. (US), Medtronic, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Siemens AG (Germany), LifeScan, Inc. (US), LifeSensors Inc. (US), Nova Biomedical Corp. (US), Acon Laboratories Inc. (US), Universal Biosensors (Australia), Pharmaco-Kinesis Corporation (PKC) (US), Bayer Healthcare AG (Germany), Biacore (UK), Bio-Rad Laboratories Inc. (US), Biosensors International Ltd. (Singapore), Ercon, Inc. (US), DuPont (US), and Sysmex Corporation (Japan).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst